SKINMEDICA WITHDRAWS IPO, CITES MARKET CONDITIONS

SkinMedica Inc., which makes products to treat dermatologic conditions and diseases, withdrew on Thursday its planned initial public offering of common stock due to market conditions. Before pulling its IPO registration statement with the U.S. Securities and Exchange Commission, the company had planned to sell 5.25 million shares for between $11 and $13 per share and had hired SG Cowen & Co. to lead a group of four underwriters.

Reuters (http://yahoo.reuters.com/financeQuoteCompanyNewsArticle.jhtml?duid=mtfh79318_2005-10-20_20-08-22_wbt004058_newsml)